Loading market dashboard
Cellebrite DI Ltd.
CLBTTechnologyNASDAQIL
Loading disclosure news
News and disclosures filtered by period, publisher, and event group.
Select a headline to open the full news page in the app.
/PRNewswire/ -- Cellebrite DI Ltd. (NASDAQ: CLBT), ein weltweit führender Anbieter von KI-gestützten Lösungen für digitale Ermittlungen und
Cellebrite Announces Upcoming Investor Events on June 10, 2026 PR Newswire TYSONS CORNER, Va. and PETAH TIKVA, I
Credo, Cellebrite, and TransMedics are building dominant positions in huge markets with years of expansion still ahead.
TYSONS CORNER, Va. and PETAH TIKVA, Israel, June 5, 2026 /PRNewswire/ -- Cellebrite DI Ltd.
Cellebrite DI NASDAQ: CLBT executives said the company is seeing broader customer adoption of its digital investigations platform, with artificial intelligence, cloud migration and U.S. federal authorization expected to shape its next phase of growth.
Cognyte and Cellebrite are riding AI-driven investigative demand - dig into their growth, profitability, valuation and risks to see which offers better upside.
Cellebrite DI NASDAQ: CLBT executives said the digital investigations company is seeing renewed momentum in government demand, international markets and new product categories, including artificial intelligence and defense-focused capabilities, during a JPMorgan cybersecurity and DevOps event hosted by analyst Brian Essex.
Cellebrite DI Ltd. (CLBT) Presents at J.P.
Cellebrite delivered strong Q1 2026 results, with 19% revenue growth and notable subscription and ARR gains, beating analyst expectations. CLBT expanded its portfolio with the SCG Canada acquisition and launched AI-powered solutions, positioning itself for long-term growth and broader market reach. Despite robust top-line growth, gross, operating, and net margins declined; margin expansion remains a key area to monitor.
Cellebrite DI Ltd. (CLBT) Q1 2026 Earnings Call Transcript
Cellebrite DI NASDAQ: CLBT reported first-quarter 2026 results that management said met or exceeded the high end of its guidance for annual recurring revenue and adjusted EBITDA, while executives highlighted a wave of new product launches centered on artificial intelligence, cloud-based case management and mobile device access.
Cellebrite DI Ltd. (CLBT) came out with quarterly earnings of $0.12 per share, beating the Zacks Consensus Estimate of $0.11 per share.
First-Quarter ARR Growth of 21% and TTM Free Cash Flow Margin of 32% Q2 Outlook Highlights ARR Acceleration TYSONS CORNER, Va. and PETAH TIKVA, Israel, May 14, 2026 /PRNewswire/ -- Cellebrite DI Ltd.
Alphabet vies for biggest company spot, markets post another record week, and more
TYSONS CORNER, Va. and PETAH TIKVA, Israel, May 8, 2026 /PRNewswire/ -- Cellebrite DI Ltd.
/PRNewswire/ -- Cellebrite DI Ltd. (Nasdaq: CLBT), líder mundial en soluciones de inteligencia e investigación digital basadas en IA para los sectores público
Authorization at the highest security standard in the FedRAMP framework enables federal government examiners, investigators, intelligence analysts and field agents to securely collaborate and act on digital evidence TYSONS CORNER, Va., May 6, 2026 /PRNewswire/ -- Cellebrite DI Ltd.
Explore the exciting world of Cellebrite (CLBT +2.69%) with our contributing expert analysts in this Motley Fool Scoreboard episode. Check out the video below to gain valuable insights into market trends and potential investment opportunities!
/PRNewswire/ -- Cellebrite DI Ltd. (Nasdaq: CLBT), ein weltweit führender Anbieter von KI-gestützten Lösungen für digitale Ermittlungen und
/PRNewswire/ -- Cellebrite DI Ltd. (Nasdaq: CLBT), leader mondial des solutions d'enquête et de renseignement numériques alimentées par l'IA, a annoncé
/PRNewswire/ -- Cellebrite DI Ltd. (Nasdaq: CLBT), líder mundial en soluciones de inteligencia e investigación digital basadas en IA, anunció hoy el
Ronnen Armon to Retire TYSONS CORNER, Va. and PETAH TIKVA, Israel, April 30, 2026 /PRNewswire/ -- Cellebrite DI Ltd.
Shares of Cellebrite DI Ltd. (NASDAQ: CLBT - Get Free Report) have been assigned a consensus recommendation of "Moderate Buy" from the five analysts that are covering the firm, Marketbeat Ratings reports. One research analyst has rated the stock with a sell recommendation and four have given a buy recommendation to the company. The average 12
TYSONS CORNER, Va. and PETAH TIKVA, Israel, April 21, 2026 /PRNewswire/ -- Cellebrite DI Ltd.
/PRNewswire/ -- Cellebrite DI Ltd. (Nasdaq: CLBT), líder mundial en soluciones de inteligencia e investigación digital basadas en IA para los sectores público
/PRNewswire/ -- Cellebrite DI Ltd. (Nasdaq: CLBT), ein weltweit führender Anbieter von KI-gestützten Lösungen für digitale Ermittlungen und
Hundreds gathered to recognize the best and brightest in digital investigations TYSONS CORNER, Va. and PETAH TIKVA, Israel, April 15, 2026 /PRNewswire/ -- Cellebrite DI Ltd.
Shares of Cellebrite DI Ltd. (NASDAQ: CLBT - Get Free Report) reached a new 52-week low during trading on Friday. The stock traded as low as $11.30 and last traded at $11.6640, with a volume of 947531 shares changing hands. The stock had previously closed at $12.41. Analyst Upgrades and Downgrades CLBT has been the
Paychex (NASDAQ: PAYX - Get Free Report) and Cellebrite DI (NASDAQ: CLBT - Get Free Report) are both computer and technology companies, but which is the better business? We will contrast the two companies based on the strength of their risk, analyst recommendations, institutional ownership, valuation, profitability, earnings and dividends. Risk and Volatility Paychex has a beta
Cellebrite DI operates in a niche with strong regulatory moats, high switching costs, and robust customer entrenchment. CLBT's financials are solid: subscription revenue up 21%, ARR at $481M, Rule of 40 above 55, and FCF margin at 34%. AI integration enhances CLBT's value proposition, accelerating evidence discovery and reinforcing its competitive positioning and growth prospects.
/PRNewswire/ -- Cellebrite DI Ltd. (Nasdaq: CLBT), leader mondial des solutions numériques d'investigation et de renseignement alimentées par l'IA pour les
/PRNewswire/ -- Cellebrite DI Ltd. (Nasdaq: CLBT), ein weltweit führender Anbieter von KI-gestützten digitalen Ermittlungs- und Aufklärungslösungen für den
Now offering access to the widest range of devices and operating systems and expanding availability of Corellium on Google Cloud TYSONS CORNER, Va. and PETAH TIKVA, Israel, March 31, 2026 /PRNewswire/ -- Cellebrite DI Ltd.
/PRNewswire/ -- Cellebrite (NASDAQ: CLBT), líder mundial en soluciones de inteligencia e investigación digital basadas en IA para los sectores público y
/PRNewswire/ -- Cellebrite (NASDAQ: CLBT), líder mundial en soluciones de investigación e inteligencia digital impulsadas por IA para los sectores público y
/PRNewswire/ -- Cellebrite (NASDAQ: CLBT), ein weltweit führender Anbieter von KI-gestützten digitalen Ermittlungs- und Aufklärungslösungen für den
/PRNewswire/ -- Cellebrite (NASDAQ: CLBT), leader mondial des solutions numériques d'investigation et de renseignement alimentées par l'IA pour les secteurs
Investigators and AI agents together resolve cases faster across departments and agencies TYSONS CORNER, Va. and PETAH TIKVA, Israel, March 18, 2026 /PRNewswire/ -- Cellebrite (NASDAQ: CLBT), a global leader in AI-powered Digital Investigative and Intelligence solutions for the public and private sectors, today announced the worldwide general availability of Guardian Investigate, a collaborative AI-powered investigative management solution that delivers a suite of capabilities for daily workflow collaboration across investigators, departments and agencies.
Top insights from the latest market news from Tuesday, March 17, from The Motley Fool analysts on Team Rule Breakers and Team Hidden Gems.
Genesis to partner closely with detectives and investigators to convert tasks from weeks to minutes and turn mountains of artifacts into actionable insights TYSONS CORNER, Va. and PETAH TIKVA, Israel, March 16, 2026 /PRNewswire/ -- Cellebrite (NASDAQ: CLBT), a global leader in AI-powered Digital Investigative and Intelligence solutions for the public and private sectors, today introduced early access to Cellebrite Genesis, a new purpose-built agentic AI product revolutionizing the way investigations get conducted.
ArrowMark Colorado Holdings LLC grew its holdings in Cellebrite DI Ltd. (NASDAQ: CLBT) by 5.0% during the third quarter, according to the company in its most recent filing with the SEC. The fund owned 1,327,882 shares of the company's stock after acquiring an additional 63,599 shares during the quarter. ArrowMark Colorado Holdings LLC
